Literature DB >> 10739520

The preterm prediction study: cervical lactoferrin concentration, other markers of lower genital tract infection, and preterm birth. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network.

R L Goldenberg1, W W Andrews, R L Guerrant, M Newman, B Mercer, J Iams, P Meis, A Moawad, A Das, J P VanDorsten, S N Caritis, G Thurnau, S Bottoms, M Miodovnik, D McNellis, J M Roberts.   

Abstract

OBJECTIVE: This study was undertaken to determine the relationship among cervical lactoferrin concentration, other cervical markers potentially related to infection, and spontaneous preterm birth. STUDY
DESIGN: Cervical lactoferrin concentrations obtained at 22 to 24 weeks' gestation among 121 women who had a spontaneous preterm birth <35 weeks' gestation were compared with cervical lactoferrin concentrations among 121 women matched for race, parity, and center who were delivered at >/=37 weeks' gestation. Results were compared against levels of cervical interleukin 6, fetal fibronectin, and sialidase, against cervical length according to ultrasonography, and according to the bacterial vaginosis Gram stain score.
RESULTS: Cervical lactoferrin concentrations ranged from not measurable (19% of the concentrations were below the threshold for this assay) to a titer of >/=1:64. There was no significant difference in the overall distributions of lactoferrin concentrations between the case patients and control subjects (P =.18). Only when the highest titers of lactoferrin were considered were there more women in the spontaneous preterm birth group (6/121 vs 0/121; P =.03). According to Spearman correlation analyses the cervical lactoferrin concentrations were strongly related to interleukin 6 concentration (r =.51; P =.0001), sialidase activity (r =.38; P =.0001), and bacterial vaginosis (r =.38; P =.0001), were weakly related to fetal fibronectin (r =. 16; P =.01), and were not related to cervical length. With the 90th percentile (a dilution of 1:32) used as a cutoff to establish a dichotomous variable, lactoferrin concentration had the following odds ratios and 95% confidence intervals for associations with other potential markers of infection: bacterial vaginosis odds ratio, 4.8 (95% confidence interval, 2.2-10.3); interleukin 6 concentration odds ratio, 2.8 (95% confidence interval, 1.2-6.5); sialidase activity odds ratio, 5. 5 (95% confidence interval, 2.2-13.7); fetal fibronectin concentration odds ratio, 0.6 (95% confidence interval, 0.2-2.0); chlamydiosis odds ratio, 2.3 (95% confidence interval, 0.8-6.9); and short cervix odds ratio, 0.5 (95% confidence interval, 0.2-1.4).
CONCLUSIONS: Lactoferrin found in the cervix correlated well with other markers of lower genital tract infection. High lactoferrin levels were associated with spontaneous preterm birth but had a very low predictive sensitivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10739520     DOI: 10.1067/mob.2000.104211

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  Associations of LINE-1 DNA Methylation with Preterm Birth in a Prospective Cohort Study.

Authors:  Heather H Burris; Sheryl L Rifas-Shiman; Andrea Baccarelli; Letizia Tarantini; Caroline E Boeke; Ken Kleinman; Augusto A Litonjua; Janet W Rich-Edwards; Matthew W Gillman
Journal:  J Dev Orig Health Dis       Date:  2012-06       Impact factor: 2.401

Review 2.  Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology.

Authors:  Robert K McNamara; Jennifer J Vannest; Christina J Valentine
Journal:  World J Psychiatry       Date:  2015-03-22

3.  Cervicovaginal microbial communities deficient in Lactobacillus species are associated with second trimester short cervix.

Authors:  Kristin D Gerson; Clare McCarthy; Michal A Elovitz; Jacques Ravel; Mary D Sammel; Heather H Burris
Journal:  Am J Obstet Gynecol       Date:  2019-12-06       Impact factor: 8.661

4.  Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study.

Authors:  Lisa D Levine; Katheryne L Downes; Julie A Romero; Hope Pappas; Michal A Elovitz
Journal:  J Matern Fetal Neonatal Med       Date:  2018-05-15

5.  Influence of iron status on risk of maternal or neonatal infection and on neonatal mortality with an emphasis on developing countries.

Authors:  Loretta Brabin; Bernard J Brabin; Sabine Gies
Journal:  Nutr Rev       Date:  2013-06-06       Impact factor: 7.110

6.  Association between length of gestation and cervical DNA methylation of PTGER2 and LINE 1-HS.

Authors:  Heather H Burris; Andrea A Baccarelli; Valeria Motta; Hyang-Min Byun; Allan C Just; Adriana Mercado-Garcia; Joel Schwartz; Katherine Svensson; Martha M Téllez-Rojo; Robert O Wright
Journal:  Epigenetics       Date:  2014-05-14       Impact factor: 4.528

7.  Multiplex immunoassay of lower genital tract mucosal fluid from women attending an urban STD clinic shows broadly increased IL1ß and lactoferrin.

Authors:  Gregory T Spear; Sabrina R Kendrick; Hua Y Chen; Tin T Thomas; Mieoak Bahk; Robert Balderas; Santosh Ghosh; Aaron Weinberg; Alan L Landay
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

8.  Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.

Authors:  Geert Zegels; Geert Aa Van Raemdonck; Wiebren Aa Tjalma; Xaveer Wm Van Ostade
Journal:  Proteome Sci       Date:  2010-12-08       Impact factor: 2.480

9.  Mucosal lactoferrin response to genital tract infections is associated with iron and nutritional biomarkers in young Burkinabé women.

Authors:  S A Roberts; L Brabin; S Diallo; S Gies; A Nelson; C Stewart; D W Swinkels; A J Geurts-Moespot; A Kazienga; S Ouedraogo; U D'Alessandro; H Tinto; B J Brabin
Journal:  Eur J Clin Nutr       Date:  2019-06-05       Impact factor: 4.016

10.  Cervical mucus properties stratify risk for preterm birth.

Authors:  Agatha S Critchfield; Grace Yao; Aditya Jaishankar; Ronn S Friedlander; Oliver Lieleg; Patrick S Doyle; Gareth McKinley; Michael House; Katharina Ribbeck
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.